Non-genomic uterorelaxant actions of corticosteroid hormones in rats: An in vitro and in vivo study.

[1]  R. Gáspár,et al.  Non-genomic actions of sex hormones on pregnant uterine contractility in rats: An in vitro study at term. , 2020, Life sciences.

[2]  Alistair R W Williams,et al.  Physiology of the endometrium and regulation of menstruation. , 2020, Physiological reviews.

[3]  Moom R. Roosan,et al.  Glucocorticoids rapidly activate cAMP production via Gαs to initiate non‐genomic signaling that contributes to one‐third of their canonical genomic effects , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Reynold A Panettieri,et al.  Non-genomic Effects of Glucocorticoids: An Updated View. , 2019, Trends in pharmacological sciences.

[5]  C. Mullan.  Management of preterm labour , 2018, Obstetrics, Gynaecology & Reproductive Medicine.

[6]  R. Gáspár,et al.  Identification of myoelectric signals of pregnant rat uterus: new method to detect myometrial contraction , 2017, Croatian medical journal.

[7]  R. Gáspár,et al.  Correlation between slow-wave myoelectric signals and mechanical contractions in the gastrointestinal tract: Advanced electromyographic method in rats. , 2016, Journal of pharmacological and toxicological methods.

[8]  A. Rudine,et al.  Effects of antenatal glucocorticoids on the developing brain , 2016, Steroids.

[9]  H. Gong,et al.  Dexamethasone rapidly inhibits glucose uptake via non-genomic mechanisms in contracting myotubes. , 2016, Archives of biochemistry and biophysics.

[10]  N. Nesseler,et al.  Fludrocortisone and Hydrocortisone, Alone or in Combination, on In Vivo Hemodynamics and In Vitro Vascular Reactivity in Normal and Endotoxemic Rats: A Randomized Factorial Design Study , 2014, Journal of cardiovascular pharmacology.

[11]  C. Jiang,et al.  Why do we need nongenomic glucocorticoid mechanisms? , 2014, Frontiers in Neuroendocrinology.

[12]  G. Mutungi,et al.  A membrane glucocorticoid receptor mediates the rapid/non‐genomic actions of glucocorticoids in mammalian skeletal muscle fibres , 2013, The Journal of physiology.

[13]  Richard E. White,et al.  GPER: a novel target for non-genomic estrogen action in the cardiovascular system. , 2013, Pharmacological research.

[14]  R. Feldman,et al.  Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. , 2013, American journal of physiology. Cell physiology.

[15]  Yan Liu,et al.  Glucocorticoid decreases airway tone via a nongenomic pathway , 2012, Respiratory Physiology & Neurobiology.

[16]  E. R. Kloet,et al.  Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling , 2012, Molecular and Cellular Endocrinology.

[17]  Minggao Li,et al.  [Rapid inhibitory effect of glucocorticoids on peak of [Ca2+]i and PLC in airway smooth muscle]. , 2010, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology.

[18]  A. Alangari.  Genomic and non-genomic actions of glucocorticoids in asthma , 2010, Annals of thoracic medicine.

[19]  B. Schmidt.  Rapid non-genomic effects of aldosterone on the renal vasculature , 2008, Steroids.

[20]  E. Levin,et al.  Extranuclear steroid receptors: nature and actions. , 2007, Endocrine reviews.

[21]  M. Perusquía.  Nongenomic action of steroids in myometrial contractility , 2001, Endocrine.

[22]  S. Di,et al.  Minireview: rapid glucocorticoid signaling via membrane-associated receptors. , 2006, Endocrinology.

[23]  Lei Liu,et al.  Rapid inhibitory effect of glucocorticoids on airway smooth muscle contractions in guinea pigs , 2006, Steroids.

[24]  A. Wanner,et al.  Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma , 2006, European Respiratory Journal.

[25]  M. Dallman.  Fast glucocorticoid actions on brain: Back to the future , 2005, Frontiers in Neuroendocrinology.

[26]  A. Mihailidou,et al.  Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system , 2005, Steroids.

[27]  J. Reel,et al.  In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  Martin Wehling,et al.  Nongenomic actions of steroid hormones , 2003, Nature Reviews Molecular Cell Biology.

[29]  J. Shapiro,et al.  Rapid Effects of Aldosterone and Spironolactone in the Isolated Working Rat Heart , 2002, Hypertension.

[30]  E. Falkenstein,et al.  Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. , 2000, Pharmacological reviews.

[31]  G. Pei,et al.  Nongenomic mechanisms of glucocorticoid inhibition of nicotine-induced calcium influx in PC12 cells: involvement of protein kinase C. , 1998, Endocrinology.

[32]  W. Nothnick,et al.  Mifepristone and ovarian function. , 1996, Clinical obstetrics and gynecology.

[33]  V. Martínez,et al.  Genomic and non-genomic effects of steroidal drugs on smooth muscle contraction in vitro. , 1994, Life sciences.

[34]  N. Narayanan.  Effects of adrenalectomy and in vivo administration of dexamethasone on ATP-dependent calcium accumulation by sarcoplasmic reticulum from rat heart. , 1983, Journal of molecular and cellular cardiology.

[35]  A. Knifton,et al.  Effects of adrenal corticosteroids on the motility of the uterus in vitro. , 1973, Research in veterinary science.